Revolutionizing diagnostics


CRISPR-Cas: a revolutionary technology

CRISPR-Cas is the among the most important discoveries in the field of biotechnology in the last decades, making great impact in a wide range of fields. Scope Biosciences uses CRISPR-Cas’ inherent specificity and ease of use to develop a point of care diagnostic platform which will revolutionize the field of medical diagnostics.


Our dream is to create a platform for diagnostics adaptable to various disease markers and revolutionize the healthcare industry. Scope Biosciences developed a state-of-the-art CRISPR based diagnostic platform in collaboration with Wageningen University and Research.  If you have any questions, please contact us